HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hao Zhang Selected Research

uK-ATP-1 potassium channel

1/2017Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hao Zhang Research Topics

Disease

618Neoplasms (Cancer)
11/2022 - 01/2002
161Inflammation (Inflammations)
08/2022 - 05/2002
107Neoplasm Metastasis (Metastasis)
12/2022 - 11/2002
100Infections
08/2022 - 01/2004
84Breast Neoplasms (Breast Cancer)
06/2022 - 03/2004
66Hypoxia (Hypoxemia)
10/2022 - 12/2005
62Carcinogenesis
03/2022 - 03/2004
59Hepatocellular Carcinoma (Hepatoma)
06/2022 - 08/2002
55Wounds and Injuries (Trauma)
12/2022 - 01/2006
54Stroke (Strokes)
11/2022 - 01/2011
50Body Weight (Weight, Body)
05/2022 - 11/2004
47Glioma (Gliomas)
07/2022 - 07/2007
42Fibrosis (Cirrhosis)
06/2022 - 05/2002
42Myocardial Infarction
01/2022 - 10/2005
40Stomach Neoplasms (Stomach Cancer)
12/2022 - 10/2005
40Papillary Thyroid Cancer
01/2022 - 09/2012
36Pain (Aches)
10/2022 - 01/2002
35Lung Neoplasms (Lung Cancer)
12/2022 - 12/2005
33Ischemic Stroke
07/2022 - 01/2011
32Carcinoma (Carcinomatosis)
07/2022 - 07/2003
32Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 10/2006
31Leukemia
01/2022 - 12/2007
30Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 01/2002
29Ischemia
08/2022 - 05/2007
29Obesity
06/2022 - 12/2009
29Prostatic Neoplasms (Prostate Cancer)
01/2022 - 11/2002
28Hypertension (High Blood Pressure)
11/2022 - 09/2007
28Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 03/2007
27Atrial Fibrillation
01/2022 - 02/2002
26Type 2 Diabetes Mellitus (MODY)
10/2022 - 05/2006
25Reperfusion Injury
12/2022 - 12/2012
25Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 04/2003
23Insulin Resistance
06/2022 - 01/2009
23Heart Failure
01/2022 - 11/2007
21Fetal Growth Retardation (Intrauterine Growth Retardation)
06/2022 - 10/2017
21Colitis
05/2022 - 08/2012
20Adenocarcinoma
08/2022 - 01/2004
20Mitochondrial Diseases (Mitochondrial Disease)
03/2022 - 01/2014
20Esophageal Squamous Cell Carcinoma
01/2022 - 01/2007
19Dysbiosis
08/2022 - 01/2018
18Non-alcoholic Fatty Liver Disease
07/2022 - 06/2018
18Lymphatic Metastasis
02/2022 - 03/2007
18Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 11/2010
18Sepsis (Septicemia)
01/2022 - 10/2010
18Adenocarcinoma of Lung
01/2022 - 01/2007
18Necrosis
01/2022 - 08/2002
18Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 12/2007
17Acute Kidney Injury (Acute Renal Failure)
12/2022 - 01/2017
17Liver Neoplasms (Liver Cancer)
12/2022 - 06/2010
17Glioblastoma (Glioblastoma Multiforme)
10/2022 - 08/2008
17Thyroid Neoplasms (Thyroid Cancer)
05/2022 - 01/2013
17Osteoporosis
05/2022 - 11/2009
17Infarction (Infarctions)
01/2022 - 10/2005

Drug/Important Bio-Agent (IBA)

230Proteins (Proteins, Gene)FDA Link
10/2022 - 04/2003
119Biomarkers (Surrogate Marker)IBA
12/2022 - 10/2006
85Pharmaceutical PreparationsIBA
07/2022 - 11/2003
72MicroRNAs (MicroRNA)IBA
08/2022 - 11/2007
67Messenger RNA (mRNA)IBA
10/2022 - 01/2004
66CytokinesIBA
05/2022 - 02/2007
55Glucose (Dextrose)FDA LinkGeneric
10/2022 - 08/2006
55Biological ProductsIBA
08/2022 - 02/2007
48Long Noncoding RNAIBA
06/2022 - 09/2015
47RNA (Ribonucleic Acid)IBA
08/2022 - 11/2002
42Therapeutic UsesIBA
09/2022 - 05/2004
38EnzymesIBA
06/2022 - 03/2004
38DNA (Deoxyribonucleic Acid)IBA
04/2022 - 10/2002
35AntioxidantsIBA
07/2022 - 08/2012
33LipidsIBA
07/2022 - 09/2010
33Small Interfering RNA (siRNA)IBA
01/2022 - 07/2009
30Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2022 - 05/2004
29CateninsIBA
02/2022 - 07/2014
27Phosphotransferases (Kinase)IBA
01/2022 - 08/2002
26Reactive Oxygen Species (Oxygen Radicals)IBA
10/2022 - 03/2013
26Interleukin-6 (Interleukin 6)IBA
01/2022 - 09/2007
26Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 01/2009
25Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2004
24Peptides (Polypeptides)IBA
01/2022 - 12/2003
23Indicators and Reagents (Reagents)IBA
01/2022 - 08/2002
22Blood Glucose (Blood Sugar)IBA
11/2022 - 01/2009
22Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 04/2009
21Neuroprotective AgentsIBA
01/2022 - 01/2013
20Peroxidase (Myeloperoxidase)IBA
01/2021 - 01/2002
19Calcitriol Receptors (Calcitriol Receptor)IBA
04/2022 - 12/2009
19AlbuminsIBA
01/2022 - 09/2007
19C-Reactive ProteinIBA
01/2022 - 11/2005
17Oxygen (Dioxygen)IBA
12/2022 - 06/2007
17CollagenIBA
12/2022 - 02/2006
17Vitamin DFDA LinkGeneric
11/2022 - 01/2011
17Circular RNAIBA
07/2022 - 01/2017
17Cisplatin (Platino)FDA LinkGeneric
01/2022 - 09/2011

Therapy/Procedure

261Therapeutics
11/2022 - 01/2002
74Drug Therapy (Chemotherapy)
10/2022 - 08/2002
42Immunotherapy
10/2022 - 01/2014
38Radiotherapy
10/2022 - 03/2007
24Precision Medicine
07/2022 - 01/2015
23Lasers (Laser)
01/2022 - 10/2006
21Transplantation
11/2022 - 01/2002
21Photothermal Therapy
01/2022 - 06/2013
19Length of Stay
07/2022 - 02/2002
19Oral Administration
03/2022 - 10/2007